CXCR4 and acute lymphoblastic leukemia: When such interactions are inhibited, for example by using AMD3100, next generation CXCR4 inhibitors or integrin-blocking strategies, BCP-ALL cells are mobilized and become easier to eradicate with conventional chemotherapy [5,7,28,40,41,42].